BioSpace News Archive

Business

Terumo Cardiovascular Group and Talis Clinical Announce Partnership to Deliver Intelligent, Real-Time Guidances to CVOR and CVICU to Improve Outcomes

Terumo Cardiovascular Group and Talis Clinical today announced a global strategic partnership.

January 23, 2019
·
3 min read
BIOREM Announces Orders Totalling $3.6 Million

BIOREM (TSXV: BRM) (“BIOREM” or “the Company”) today announced two new orders totalling $3.6 million. The orders are for air emission abatement projects in China and North America.

January 23, 2019
·
1 min read
FDA

FDA approves use of 0.5 mL dose of Fluzone® Quadrivalent (influenza vaccine) in children as young as 6 months of age

The 0.5 mL dose is now approved for use in children 6 months through 35 months of age

January 23, 2019
·
6 min read
Business

Orthopedic Institute and CORE Orthopedics Announce Partnership

Two regional orthopedic groups team up to strengthen patient-centered approach to orthopedic care.

January 23, 2019
·
3 min read
Scan 2D coded tubes in seconds

Micronic is pleased to announce the release of the new Micronic Rack Reader DR500 complete with in-house designed Micronic Code Reader Software.

January 23, 2019
·
2 min read
PAA showcases automation solutions that break the mould at SLAS2019

Peak Analysis & Automation (PAA), a global leader in laboratory automation for over 30 years, will be showcasing its range of innovative, cutting-edge automation solutions and providing expert automation advice on booth 1429 at the SLAS2019 conference in Washington, DC, February 2-6th 2019.

January 23, 2019
·
3 min read
Genetown

Sareum licence partner for SRA737, Sierra Oncology, to Present at the DNA Damage Response Therapeutics Summit on 30 January 2019

Sareum Holdings plc (AIM: SAR), the specialist small molecule drug development business, notes that Sierra Oncology, the licence holder advancing clinical cancer candidate SRA737, has announced that its Chief Scientific Officer, Dr. Christian Hassig, will present “Addressing Intrinsic & Acquired PARP Inhibitor (PARPi) Resistance Through Chk1 Inhibition” at the DNA Damage Response (DDR) Therapeutics Summit in Boston, MA.

January 23, 2019
·
3 min read
Business

DR. LEILEI SHINOHARA JOINS ROBOSENSE AS VICE PRESIDENT OF R&D SHINOHARA WAS PREVIOUSLY LEAD FOR THE WORLD’S FIRST AUTOMOTIVE GRADE LIDAR PRODUCT --VALEO SCALA 50

RoboSense, a leader in LiDAR perception technology, announced today that Dr. Leilei Shinohara has joined RoboSense as Vice President of R&D

January 23, 2019
·
4 min read
Demand for Neurovascular Thrombectomy Devices to Surge on Account of Growing Incidences of Acute Ischemic Stroke

Thrombectomy is a surgical procedure to remove the blood clots formed in the blood vessel. Cerebral infraction is an ischemic stroke that results in lack of blood supply to the brain. Neurovascular thrombectomy devices also known as cerebral thrombectomy devices are used to retrieve or destroy the blood clots in the cerebral region.

January 23, 2019
·
3 min read
Business

Scilligence Joins Accenture’s Life Sciences Research Platform Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research

Scilligence, a provider of mobile cheminformatics and bioinformatics for the life sciences industry, has joined the Accenture research platform open partner ecosystem, which will allow for the integration of Scilligence’s informatics solutions

January 23, 2019
·
2 min read